New Stock Tracker from Clinica
This article was originally published in Clinica
Executive Summary
Stock Highlight: Medgenics (MEDG) -10% Medgenics, a developer of biopump technology for treating chronic diseases, has managed to keep its share price on a fairly even keel after its debut on the London Stock Exchange's alternative investment market (AIM). The Misgav, Israel-based firm's first three months as a publicly-listed entity coincided unhappily with the recent financial turmoil that has been experienced in the US.